Biomedical research at Oslo University Hospital

Oslo University Hospital is a merger of three former university hospitals in Oslo. Biomedical research is one of the hospital's core activities. Research at the hospital is closely interlinked with research undertaken at the University of Oslo. More than 50% of all biomedical research in Norway is published by researchers affiliated with the hospital. Research undertaken cover both basic research, translational research, and clinical research.

Oslo University Hospital has a central role in developing and supporting biomedical research within the South-Eastern Regional Health Authority. The hospital also pursues international research collaborations.

Click here to see hierarchical division and subunit overview

Summary of publications:

Publications (original articles or review articles) published in 2020 from OUS - Department of Urology

12 publications found

Berger I, Aamodt H, Jorgensen K, Berland S, Sitek JC, Johansen TEB, Rodriguez JR (2020)
Birt-Hogg-Dube-syndrome
Tidsskr. Nor. Laegeforen., 140 (6), 565-569

Cai T, Cocci A, Gacci M, Verze P, Bonkat G, Koves B, Wagenlehner F, Bartoletti R, Bjerklund Johansen TE (2020)
Guidelines in urology: Lights and shadows
Urologia, 87 (3), 125-129
DOI 10.1177/0391560320917805, PubMed 32342733

Cai T, Tamanini I, Mattevi D, Verze P, Palmieri A, Malossini G, Mirone V, Novelli A, Tascini C, Johansen TEB (2020)
Fosfomycin trometamol and N-acetyl-L-cysteine as combined oral therapy of difficult-to-treat chronic bacterial prostatitis: Results of a pilot study
Int J Antimicrob Agents, 56 (1), 105935
DOI 10.1016/j.ijantimicag.2020.105935, PubMed 32156620

Cai T, Tiscione D, Favilla V, Puglisi M, Palumbo F, Zucchi A, Malossini G, Palmieri A, Bjerklund Johansen TE (2020)
Oral Administration and Intralesional Injection of Hyaluronic Acid Versus Intralesional Injection Alone in Peyronie's Disease: Results from a Phase III Study
World J Mens Health (in press)
DOI 10.5534/wjmh.200048, PubMed 33151042

Dahl AA, Brennhovd B, Fosså SD, Axcrona K (2020)
A cross-sectional study of current work ability after radical prostatectomy
BMC Urol, 20 (1), 9
DOI 10.1186/s12894-020-0579-9, PubMed 32005115

Dahl AA, Fosså SD, Brennhovd B, Axcrona K (2020)
The EPIC-26 domain scores after radical prostatectomy are associated with the personality trait of neuroticism
Int Urol Nephrol
DOI 10.1007/s11255-020-02688-4, PubMed 33118115

Ersvaer E, Hveem TS, Vlatkovic L, Brennhovd B, Kleppe A, Tobin KAR, Pradhan M, Cyll K, Waehre H, Kerr DJ, Danielsen HE (2020)
Prognostic value of DNA ploidy and automated assessment of stroma fraction in prostate cancer
Int J Cancer, 147 (4), 1228-1234
DOI 10.1002/ijc.32832, PubMed 31846064

Fosså SD, Aas K, Müller C, Jerm MB, Tandstad T, Lilleby W, Kvåle R, Gulbrandsen J, Haug E, Myklebust TA (2020)
Definitive radiotherapy for prostate cancer in Norway 2006-2015: Temporal trends, performance and survival
Radiother Oncol, 155, 33-41 (in press)
DOI 10.1016/j.radonc.2020.10.022, PubMed 33096165

Grummet J, Gorin MA, Popert R, O'Brien T, Lamb AD, Hadaschik B, Radtke JP, Wagenlehner F, Baco E, Moore CM, Emberton M, George AK, Davis JW, Szabo RJ, Buckley R, Loblaw A, Allaway M, Kastner C, Briers E, Royce PL, Frydenberg M, Murphy DG, Woo HH (2020)
"TREXIT 2020": why the time to abandon transrectal prostate biopsy starts now
Prostate Cancer Prostatic Dis, 23 (1), 62-65
DOI 10.1038/s41391-020-0204-8, PubMed 31932659

Ottosson F, Baco E, Lauritzen PM, Rud E (2020)
The prevalence and locations of bone metastases using whole-body MRI in treatment-naïve intermediate- and high-risk prostate cancer
Eur Radiol
DOI 10.1007/s00330-020-07363-x, PubMed 33141299

Qvigstad LF, Grøtta OJ, Hammarström C, Baco E (2020)
Intractable bleeding from the renal pelvis in a patient with hereditary haemorrhagic telangiectasia (Rendu-Osler-Weber disease)
Scand J Urol, 54 (5), 449-451
DOI 10.1080/21681805.2020.1798505, PubMed 32720548

Wagenlehner FME, Bjerklund Johansen TE, Cai T, Koves B, Kranz J, Pilatz A, Tandogdu Z (2020)
Epidemiology, definition and treatment of complicated urinary tract infections
Nat Rev Urol, 17 (10), 586-600
DOI 10.1038/s41585-020-0362-4, PubMed 32843751

 
Page visits: 463765